๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Safe botulinum toxin type A injection in patients with history of eyelid ptosis

โœ Scribed by Fariba Ghalamkarpour; Yassaman Aghazadeh; Golaun Odabaei


Book ID
111195348
Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
511 KB
Volume
8
Category
Article
ISSN
1473-2130

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Use of botulinum toxin type F injections
โœ Dr. Paul E. Greene; Stanley Fahn ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 492 KB

## Abstract Fifteen patients with torticollis who had been treated with repeated injections of botulinum toxin type A (botox A) developed antibodies to the toxin. This resulted in loss of benefit in the 13 patients who had improved with botox A injections and failure to develop muscle atrophy after

Botulinum toxin A injections improve apr
โœ Masato Kanazawa; Takayoshi Shimohata; Masahisa Sato; Osamu Onodera; Keiko Tanaka ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 44 KB

Botulinum Toxin A Injections Improve Apraxia of Eyelid Opening without Overt Blepharospasm Associated with Neurodegenerative Diseases Apraxia of eyelid opening (AEO) designates an intermittent inability to open the eyes voluntarily. 1 AEO is observed in patients with neurodegenerative diseases, incl

Botulinum toxin A injections improve apr
โœ Eva Lopez Valdes; Ignacio Javier Posada Rodriguez; Rafael Bilbao-Calabuig ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 34 KB

We have read with interest the letter of Kanazawa 1 about improvement of apraxia of eyelid opening (AEO) with botulinum toxin A. The term AEO defined as an intermittent inability to open the eyes voluntarily is not a specific entity; it is only a clinical sign whose physiopathological origin is var